APGE
Price
$36.97
Change
-$1.30 (-3.40%)
Updated
Aug 25, 04:59 PM (EDT)
Capitalization
2.28B
85 days until earnings call
BYSI
Price
$1.78
Change
+$0.02 (+1.14%)
Updated
Aug 25, 04:07 PM (EDT)
Capitalization
70.98M
Interact to see
Advertisement

APGE vs BYSI

Header iconAPGE vs BYSI Comparison
Open Charts APGE vs BYSIBanner chart's image
Apogee Therapeutics
Price$36.97
Change-$1.30 (-3.40%)
Volume$3.62K
Capitalization2.28B
BeyondSpring
Price$1.78
Change+$0.02 (+1.14%)
Volume$100
Capitalization70.98M
APGE vs BYSI Comparison Chart in %
Loading...
APGE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BYSI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
APGE vs. BYSI commentary
Aug 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is APGE is a Hold and BYSI is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 26, 2025
Stock price -- (APGE: $38.27 vs. BYSI: $1.76)
Brand notoriety: APGE and BYSI are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: APGE: 76% vs. BYSI: 43%
Market capitalization -- APGE: $2.28B vs. BYSI: $70.98M
APGE [@Biotechnology] is valued at $2.28B. BYSI’s [@Biotechnology] market capitalization is $70.98M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.31B to $0. The average market capitalization across the [@Biotechnology] industry is $1.86B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

APGE’s FA Score shows that 0 FA rating(s) are green whileBYSI’s FA Score has 0 green FA rating(s).

  • APGE’s FA Score: 0 green, 5 red.
  • BYSI’s FA Score: 0 green, 5 red.
According to our system of comparison, APGE is a better buy in the long-term than BYSI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

APGE’s TA Score shows that 3 TA indicator(s) are bullish while BYSI’s TA Score has 4 bullish TA indicator(s).

  • APGE’s TA Score: 3 bullish, 5 bearish.
  • BYSI’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, both APGE and BYSI are a bad buy in the short-term.

Price Growth

APGE (@Biotechnology) experienced а +2.63% price change this week, while BYSI (@Biotechnology) price change was -12.87% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.14%. For the same industry, the average monthly price growth was +18.77%, and the average quarterly price growth was +29.32%.

Reported Earning Dates

APGE is expected to report earnings on Nov 18, 2025.

Industries' Descriptions

@Biotechnology (+2.14% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
APGE($2.28B) has a higher market cap than BYSI($71M). BYSI YTD gains are higher at: 7.975 vs. APGE (-15.519). BYSI has higher annual earnings (EBITDA): -8.35M vs. APGE (-270.1M). APGE has more cash in the bank: 505M vs. BYSI (9.54M). BYSI has less debt than APGE: BYSI (477K) vs APGE (10.8M). APGE (0) and BYSI (0) have equivalent revenues.
APGEBYSIAPGE / BYSI
Capitalization2.28B71M3,213%
EBITDA-270.1M-8.35M3,234%
Gain YTD-15.5197.975-195%
P/E RatioN/AN/A-
Revenue00-
Total Cash505M9.54M5,291%
Total Debt10.8M477K2,264%
FUNDAMENTALS RATINGS
BYSI: Fundamental Ratings
BYSI
OUTLOOK RATING
1..100
73
VALUATION
overvalued / fair valued / undervalued
1..100
52
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
60
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
APGEBYSI
RSI
ODDS (%)
N/A
Bullish Trend 4 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
78%
Bullish Trend 4 days ago
75%
Momentum
ODDS (%)
Bullish Trend 4 days ago
77%
Bearish Trend 4 days ago
85%
MACD
ODDS (%)
Bullish Trend 4 days ago
81%
Bearish Trend 4 days ago
88%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
85%
Bearish Trend 4 days ago
87%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
84%
Bearish Trend 4 days ago
87%
Advances
ODDS (%)
Bullish Trend 4 days ago
84%
Bullish Trend 11 days ago
82%
Declines
ODDS (%)
Bearish Trend 6 days ago
75%
Bearish Trend 6 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
88%
Bullish Trend 4 days ago
83%
Aroon
ODDS (%)
Bearish Trend 4 days ago
89%
Bearish Trend 4 days ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
APGE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BYSI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RUDAX19.710.74
+3.90%
BNY Mellon Sm Cp Val A
PIERX31.500.51
+1.65%
Putnam International Equity R
OEQAX9.280.14
+1.53%
Oaktree Emerging Markets Equity A
GERUX10.290.13
+1.28%
Goldman Sachs Em Mkts Eq Insghts R6
FIATX34.060.36
+1.07%
Fidelity Advisor Intl Cap App M

APGE and

Correlation & Price change

A.I.dvisor indicates that over the last year, APGE has been loosely correlated with SYRE. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if APGE jumps, then SYRE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To APGE
1D Price
Change %
APGE100%
+5.28%
SYRE - APGE
54%
Loosely correlated
+3.58%
CRNX - APGE
49%
Loosely correlated
+5.17%
IDYA - APGE
48%
Loosely correlated
+1.99%
DYN - APGE
48%
Loosely correlated
+2.95%
CGON - APGE
47%
Loosely correlated
+3.60%
More

BYSI and

Correlation & Price change

A.I.dvisor indicates that over the last year, BYSI has been loosely correlated with GOSS. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if BYSI jumps, then GOSS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BYSI
1D Price
Change %
BYSI100%
N/A
GOSS - BYSI
38%
Loosely correlated
+7.83%
CYTK - BYSI
37%
Loosely correlated
+0.76%
VNDA - BYSI
33%
Poorly correlated
+5.32%
APGE - BYSI
32%
Poorly correlated
+5.28%
TAOX - BYSI
31%
Poorly correlated
+18.60%
More